Squamous, large cell, and adenocarcinoma, collectively termed non-small cell lung cancer
(NSCLC), are diagnosed in approximately 75% of patients with lung cancer in the United …

The staging of non–small cell lung cancer (NSCLC) is at a juncture; the current 7th edition of
the TNM staging system (TNM7) is about to be superseded by the widespread adoption of …

Objectives To review the role of imaging in the diagnosis of recurrent disease in previously
treated non-small cell lung cancer (NSCLC) and discuss the imaging pitfalls. Methods A …

Background: Exact staging of ipsi-and contralateral mediastinal lymph-node metastases (N
1/2 vs. N3) is essential for the therapeutic strategy in non-small-cell lung cancer (NSCLC) …

A national, evidence-based guideline on the staging and treatment of patients with non-
small cell lung carcinoma (NSCLC) has been compiled by the various disciplines involved …

Staging of non-small-cell lung cancer is a multidisciplinary process involving imaging,
endoscopic and surgical techniques. Accuracy is vital in order to avoid false-positive …

Although the overall curerate for lung cancer is not improving it has become increasingly
recognised over the last 10 years that accurate subclassification of tumour cell types and …

Radiology and surgery are not competing but are complementary modalities in the care of
patients with lung cancer. In certain areas, such as evaluation of the solitary pulmonary …

To determine the sensitivity, specificity, and accuracy of staging mediastinal nodal disease
in potentially resectable lung cancer using fluorodeoxyglucose–positron emission …

Simple Summary The tumor, lymph node, and metastases classification of lung cancer
describes how big the tumor is and what structures it invades; whether the lymph nodes are …